Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Zohydro Maker Sues To Block Massachusetts Ban

By Pharmaceutical Processing | April 8, 2014

BOSTON (AP) — The maker of Zohydro, a controversial new prescription painkiller, has filed a lawsuit in federal court seeking to block Massachusetts’ ban on local doctors prescribing and dispensing the drug.

Zogenix filed suit in U.S. District Court in Massachusetts on Monday requesting that the court temporarily stop Massachusetts Governor Deval Patrick’s executive order. A hearing is scheduled for Tuesday afternoon, according to court records.

The San Diego-based company argues in its lawsuit that Governor Patrick’s order is at odds with the U.S. Food and Drug Administration, which approved use of Zohydro for severe pain in October.

Law enforcement and public health officials fear the powerful painkiller could worsen the nation’s deadly scourge of heroin and prescription drug abuse.

In March, Governor Patrick declared a public health emergency in response to the state’s growing epidemic of heroin and opioid addiction. As part of that announcement, the governor gave the state public health commissioner certain emergency powers, including banning Zohydro “until determined that adequate measures are in place to safeguard against the potential for diversion, overdose, and misuse.”

The ban is an “impermissible” effort by Massachusetts to set its own drug policy, Zogenix says in its suit. “It impedes the FDA’s Congressional mandate to approve a range of safe treatments to promote the public health.”

The company said the lawsuit comes after a written request to meet with Governor Patrick went unanswered. The governor’s office referred questions to the state Department of Public Health, which said late Monday that it is reviewing the complaint.

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE